Henry I. Miller M.D.
Henry I. Miller M.D.
Home  |  Bio  |  Mobile Site  |  Follow @Twitter
Pundicity: Informed Opinion and Review
 

Latest Articles

Stop Fearing AI Like the Luddites Feared the Loom
The societies that won the future were never the ones that barricaded the door. They were the ones that opened it.

August 17, 2026  •  Inside Sources

Every transformative technology has its prophets of doom. AI is just the latest to draw them out.

In the early 1800s, the "Luddites," followers of the possibly mythical Ned Ludd, smashed textile machinery, convinced that destroying the new technology would save their livelihoods. They weren't entirely misguided: Mechanized looms did largely displace artisans. But they were wrong about everything else. History doesn't remember the Luddites for foreseeing the future; it remembers them for mistaking sabotage for a strategy.

Continue to the full article  |  More articles

 

Activists vs. Scientists: Could "Butterfly Effect" fears derail gene-drive research targeting the flesh-eating screwworm?
Risk-benefit considerations favor using the newest technology

August 13, 2026  •  Genetic Literacy Project

The United States once defeated a ravenous, parasitic fly with mass releases of sterile insects. A genetically engineered strain could strengthen that defense, while CRISPR gene drives remain a more contentious possibility.

The flesh-eating New World screwworm (NWS)—a parasitic fly whose maggots feed on the living tissues of warm-blooded animals—has returned to the United States, creating a challenging agricultural biosecurity emergency across the ranchlands, border corridors, and wildlife habitat of Texas and New Mexico.

Continue to the full article  |  More articles

 

The FDA stacked a panel with peptide sellers. Guess what it voted to greenlight?
Unwitting consumers will be put at risk

July 30, 2026  •  Washington Examiner

During a meeting last week [July 23-24], the Food and Drug Administration's Pharmacy Compounding Advisory Committee recommended that six previously restricted peptides be made available for pharmacy compounding.

Peptides are short chains of amino acids, the building blocks of proteins. Compounding is the preparation of customized medications for individual patients rather than the dispensing of conventionally manufactured, FDA-approved drugs.

The committee endorsed BPC-157, KPV, TB-500, MOTS-c, Epitalon and Semax—substances promoted for conditions ranging from ulcerative colitis and wound healing to obesity, osteoporosis, insomnia and neurological disorders. Only emideltide was rejected, 7-6.

Continue to the full article  |  More articles

 

Hiroshima at 81: America's new nuclear bomb, a buried Iranian target, and a question no one wants to ask
Sometimes we're forced to choose the least bad of the alternatives

July 30, 2026  •  Genetic Literacy Project

PLEASE NOTE: The excellent photos that accompany this article did not transfer well, so to view it, please go to https://geneticliteracyproject.org/2026/07/30/hiroshima-at-81-americas-new-nuclear-bomb-a-buried-iranian-target-and-a-question-no-one-wants-to-ask/

(No paywall.)

Continue to the full article  |  More articles

 

The next bubble to pop: AI will change the world — and destroy fortunes
Unless, that is, breakthroughs arrive quickly enough and generate enough economic value to support today's extraordinary expectations

July 27, 2026  •  Washington Examiner

Few people doubt that artificial intelligence (AI) will transform our lives. AI is already changing how we write, program computers, diagnose disease, design products, conduct scientific research, and even perpetrate scams. It may ultimately prove to be as important as electricity, the automobile, or the internet.

But there is another question that deserves equal attention: Is today's enormous investment in AI justified by the value it will ultimately create?

Continue to the full article  |  More articles

home   |   biography   |   articles   |   mailing list   |   mobile site